2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene CAS 1030825-20-7 Purity ≥98.0% (HPLC)

Incazelo emfushane:

2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene

I-CAS: 1030825-20-7

Ukubukeka: Impushana Emhlophe noma Engamhlophe

Ubumsulwa: ≥98.0% (HPLC)

I-Intermediate of API (CAS: 842133-18-0) ekwelapheni uhlobo 2 lwesifo sikashukela i-Mellitus

Inquiry: alvin@ruifuchem.com

Thumela i-imeyili kithi

Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

IziMmeli Ezihlobene Nokuhlinzeka Ngomkhiqizi:
I-4-Fluorophenylboronic Acid CAS: 1765-93-1
2-(4-Fluorophenyl)thiophene CAS: 58861-48-6
2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone CAS: 32384-65-9
I-5-Iodo-2-Methylbenzoic Acid CAS 54811-38-0
2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene CAS: 1030825-20-7
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene CAS: 898566-17-1
I-CAS: 842133-18-0
I-CAS: 928672-86-0

Chemical Properties:

Igama Lekhemikhali	2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene
Inombolo ye-CAS	1030825-20-7
Inombolo yeCAT	I-RF-PI234
Isimo Sesitoko	Esitokweni, Isikali Sokukhiqiza Sifinyelela Emakhulwini Amakhilogremu
I-Molecular Formula	I-C18H14BrFS
Isisindo samangqamuzana	361.27
I-Melting Point	103℃
Ukuminyana	1.388
Ibhrendi	I-Ruifu Chemical

Imininingwane:

Into	Imininingwane
Ukubukeka	Impushana Emhlophe noma Engamhlophe
Ukuhlanzeka / Indlela Yokuhlaziya	≥98.0% (HPLC)
Ukulahlekelwa Ekumisweni	≤1.00%
Izinsalela ekushiseni	≤0.50%
Izinsimbi Ezisindayo	≤20ppm
Izinga Lokuhlola	I-Enterprise Standard
Ukusetshenziswa	I-Intermediate of API (CAS: 842133-18-0)

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama

Izinzuzo:

I-FAQ:

Isicelo:

I-Shanghai Ruifu Chemical Co., Ltd. ingumkhiqizi oholayo nomnikezeli we-2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene (CAS: 1030825-20-7) enekhwalithi ephezulu.Itiyindawo emaphakathi ngokuvamile ekuhlanganisweni kwe-API (CAS: 461432-26-8).I-API (i-CAS: 461432-26-8) iyisidakamizwa esisha se-antidiabetic esakhiwe ngokuhlanganyela yi-Bristol-Myers Squibb kanye ne-AstraZeneca, sigunyazwe yi-European Medicines Agency (EMA) ngoNovemba 12, 2012. Kuphinde kube yi-SGLT2 inhibitor yokuqala evunyelwe ukwelashwa kohlobo lwesifo sikashukela sohlobo lwesibili, okuyindlela ebalulekile ekwelapheni isifo sikashukela, futhi isetshenziselwa ukuthuthukisa ukulawulwa kwe-glycemic njengesengezo ekudleni nokuzivocavoca kwabantu abadala abanesifo sikashukela sohlobo lwe-II.